Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Unregulated exosome-based injections can cause severe skin reactions and scarring.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Minoxidil, a hair loss treatment, works better and has fewer side effects when put into tiny particles called transethosomes, especially those containing oleic acid.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Propylene glycol and ethanol increase finasteride skin absorption, sodium lauryl sulfate doesn't.

Doxazosin may cause breast enlargement and pain in men.

Ethosomes improve finasteride delivery through skin for hair loss treatment.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The method effectively showed that the two exemestane preparations are bioequivalent.

Oral minoxidil users, especially for hypertension, may risk heart issues, and better monitoring guidelines are needed for alopecia patients.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Human sebaceous glands can grow normally for a week without certain growth factors, and adding estrogen reduces their oil production without affecting cell growth.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Low-dose oral minoxidil effectively treats female hair loss with good safety.